News

Press ReleaseCell and gene therapy industry continues to expand manufacturing infrastructure in the UK
Filter:AllGeneralRegulatory NewsNewsletterExternalManufacturingPress ReleaseSkills and TrainingChallenge Theme – PATChallenge Theme – AAVChallenge Theme – iPSCsNon ClinicalCommercialisation of Research
Year:All2024202320222021 →
Press release: GE Healthcare advances the delivery of cell therapies with new thawing technologyPress release: GE Healthcare advances the delivery of cell therapies with new thawing technologyRegulatory news - August 2017Regulatory news - August 2017Press release: New investment in Cell and Gene Therapy Catapult manufacturing centrePress release: New investment in Cell and Gene Therapy Catapult manufacturing centreOxford BioMedica announces a £2 million two-year collaboration co-funded by Innovate UKOxford BioMedica announces a £2 million two-year collaboration co-funded by Innovate UKRegulatory news - July 2017Regulatory news - July 2017Budding UK innovation agency gains cash — and cloutBudding UK innovation agency gains cash — and clout£86 million funding announced for new medicine and technology£86 million funding announced for new medicine and technologyRegulatory news - June 2017Regulatory news - June 2017Designing a cell and gene therapy GMP cleanroomDesigning a cell and gene therapy GMP cleanroomPress release: Cell Medica acquisition of WT1 T-cell therapyPress release: Cell Medica acquisition of WT1 T-cell therapyConstructing the Cell and Gene Therapy Catapult manufacturing centreConstructing the Cell and Gene Therapy Catapult manufacturing centrePress release: Cell and Gene Therapy Catapult Licenses Cell Culture Data to Ajinomoto Co., Inc.Press release: Cell and Gene Therapy Catapult Licenses Cell Culture Data to Ajinomoto Co., Inc.